NCT05290441View on ClinicalTrials.gov

Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

August 15, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2022

Conditions
Pneumonia, ViralCOVID-19 PneumoniaEGFR Amplification
Interventions
PROCEDURE

None involvement

No EGFR involvement

Trial Locations (2)

16115

Bursa Yüksek İhtisas EAH, Bursa

Seyhan Dülger, Bursa

All Listed Sponsors
lead

Bursa Yuksek Ihtisas Training and Research Hospital

OTHER_GOV

NCT05290441 - Evaluation of Postmortem Pulmonary Interstitial Fibrosis Severity and EGFR Positivity in Covid-19 Pneumonia | Biotech Hunter | Biotech Hunter